|
|
|
|
 |
|||
|
|||
Volume 52 (3): 355-360, 2004
Copyright ©The Histochemical Society, Inc.
Expression of Estrogen Receptors in Human Corpus Cavernosum and Male Urethra
Division of Gynecologic Endocrinology and Reproductive Medicine (WD,JCH), University of Vienna Medical School, Vienna, Austria; Department of Clinical Pathology (AH), University of Vienna Medical School, Vienna, Austria; and Department of Urology (WJR), Korneuburg Hospital, Korneuburg, Austria
Correspondence to: Wolf Dietrich, MD, Div. of Gynecologic Endocrinology and Reproductive Medicine, Univ. of Vienna Medical School, Waehringer Guertel 18–20, 1090 Vienna, Austria. E-mail: wolf.dietrich{at}akh-wien.ac.at
 |
Summary |
|---|
 Top Summary IntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Estrogen, largely produced in testis and adrenal gland, may play important roles in male reproduction. Most of the effects of estrogens are mediated by binding of estrogen to one or both of the two estrogen receptor (ER) subtypes
and ß. Recently, they have been described in testis, prostate, and efferent ducts, mostly in rodents. The goal of this study was to prove the evidence of ERs in human corpus cavernosum and male urethra, exploring the protein expression of these receptors by immunohistochemistry. Corpus cavernosum and corpus spongiosum smooth muscle was immunoreactive for the androgen receptor (AR), ER, and strongly for ERß. Endothelial cells were negative for AR, sporadically positive for ER, and positive for ERß. Urethral epithelium showed strong nuclear expression of AR, predominantly in the basal cell layer, and nuclear expression of ER in the intermediate cells. ERß was highly expressed in almost all urethral nuclei and, much more weakly, in cytoplasm. Progesterone receptor (PGR) was negative in all cases and all tissues. These results represent the first report that ER and particularly ERß are regularly expressed in human penile tissue. (J Histochem Cytochem 52:355–360, 2004)
Key Words: estrogen receptor- • estrogen receptor-ß • androgen receptor • corpus cavernosum • endothelium • urethra
|
Introduction |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
THE ROLE of estrogen and estrogen receptors (ERs) in male reproduction has been repeatedly elucidated since estrogen was found to be produced in male genitourinary organs by Staffieri et al. (1965)
and in adrenal gland. Most of the effects of estrogens are mediated by the genomic pathway, which involves the binding of estrogen to one or both of the two ER subtypes (Gruber et al. 2002). Although the -isoform (ER) and the more recently discovered ß-isoform (ERß) contain very similar DNA-binding domains, the overall degree of homology is low and they show different binding affinity for several natural and synthetic ligands (Kuiper et al. 1997). The tissue distributions of ER and ERß differ. ER is found mainly in classic estrogen target tissues, such as breast and ovary, whereas ERß has been described in kidney, lung, bone, and endothelial cells (Makela et al. 1999; Taylor and Al-Azzawi 2000; Windahl et al. 2000). In the circulation, both receptors have been detected in vascular smooth muscle cells (Karas et al. 1994; Evans et al. 2002), e.g., of human coronary arteries, where they reduce vascular tone. Further, estrogens cause short-term vasodilatation by releasing nitric oxide (NO) (Mendelsohn and Karas 1999) and prostacyclin in endothelial cells.
Estrogens are known to stimulate growth, blood flow, and water retention in sexual organs (Jenner et al. 1972; Batra et al. 1985). There, and in the lower urinary tract, ER and ERß have been described in testis, prostate, and efferent ducts (Bodker et al. 1999; Makela et al. 2000; Salmi et al. 2001). Most of these studies have been performed in rodents, but there is only one piece of evidence of ERs in the penis (rat; Jesmin et al. 2002). The goal of our in vitro study was to prove the evidence of the two ER isoforms, as well as of the androgen receptor (AR) and the progesterone receptor (PGR), in human corpus cavernosum and male urethral tissue, exploring the protein expression of these receptors by immunohistochemistry (IHC). The results represent the first report that ER and particularly ERß are regularly expressed in human penile tissue.
|
Materials and Methods |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Tissue Samples
Specimens (n=23) were obtained from patients who underwent partial penectomy in Vienna University hospital because of squamous cell carcinoma of the penis. All cases, within 8 years from 1994 to 2001, for which representative material was available were enrolled in this study. Concerning other clinical diagnosis, probably affecting the vasculature, patients had at time of surgery eight arterial hypertension, five coronary heart disease, three non-insulin-dependent diabetes mellitus, one chronic veinous insufficiency and one adipositas. The ages of the patients at surgery were 21–87 years (mean 65.6, SD 17.5). Tissue was fixed in formalin and routinely processed in paraffin.
Immunohistochemistry
Four-µm-thick sections of the tumor-free resection edge were dewaxed and rehydrated. Deparaffinization was carried out in xylene and graded ethanols. Endogenous peroxidase was blocked by incubation in 5% H2O2 in methanol for 15 min. Heat-mediated antigen retrieval was performed by microwaving three times for 5 min at 500 W in Citra-Plus solution (BioGenex; San Ramon, CA) for ERß staining or citrate buffer (pH 6.0) for all others. Unspecific bindings were blocked using the biotin blocking system (DAKO; Carpinteria, CA). Incubation was carried out with the following antibodies in a humidified chamber:
- AR: mouse monoclonal AR441, dilution 1:100 (DAKO), 1 hr at RT.
- ER: mouse monoclonal 1D5, dilution 1:200 (DAKO), 1 hr at RT.
- ERß: mouse monoclonal 14C8, dilution 1:1500 (BioGenex), overnight at 4C.
- PGR: mouse monoclonal PgR 636 (DAKO), dilution 1:1600, 1 hr at RT.
Antibodies against AR, ER, and PGR have been well characterized by Western blotting on human recombinant receptors (detailed documentation at the manufacturer, DAKO) and are widely used in clinical routine diagnostics. The antibody raised against ERß has been characterized by absorption studies (Skliris et al. 2002). These authors found it most suitable for IHC on paraffin-embedded tissue compared to six other ERß antibodies. To further test the specificity of 1D5 and 14C8, antibodies were diluted to working concentration and preabsorbed with a 100-fold excess of the respective antigens, i.e., recombinant human ER-protein (Affinity BioReagents; Golden, CO) at 23 pmol/100 µl and recombinant human ERß-protein (Alexis Biochemicals, San Diego, CA) at 44 pmol/100 µl for 1 hr at RT. Solutions were centrifuged at 13,000 rpm for 10 min and the supernatant was used for incubation (see Figure 2
).
|
A staining procedure was carried out for all slides using the ChemMate Detection Kit (DAKO) in which diaminobenzidine is the chromogen. After a 5-min reaction, staining was interrupted by washing in PBS followed by counterstaining with Gill's hematoxylin (Merck; Darmstadt, Germany). Positive controls for ER
, ERß, PGR, and AR included previously tested and, respectively, positive breast and prostatic cancers. In the negative controls primary antibody was replaced with the respective isotype immunoglobulin (mouse IgG1 for AR441, 1D5, and PgR636; mouse IgG2a for 14C8) in the same concentration (Coulter Clone; Miami, FL). IHC was performed semiquantitatively on three sections per sample and antibody.
The intensity of nuclear staining and the number of stained cells were examined independently by two investigators (WD and AH). No significant staining was scored as 0, scattered or weak immunostaining as +, and intense immunostaining in approximately 50% or more of respective cells as ++ (Fan et al. 2002).
|
Results |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Corpus Cavernosum (CC)
Corpus cavernosum tissue was immunoreactive for AR in all cases, where nuclei of smooth muscle cells showed expression ranging from weak to strong. Endothelial cells were negative for AR in all slides (Tables 1 and 2; Figure 1) . ER
protein could be detected in the nuclei of smooth muscle cells and, sporadically, in endothelial cells in seven cases. Immunostaining ranged from moderate to very weak, and the differentiation from negative results was difficult. There was no staining of cytoplasm in any slide (Tables 1 and 2; Figure 1). However, we found moderate to strong staining of ERß in >80% of the smooth muscle cells in all CCs examined. In addition, weak immunostaining of the cytoplasm could be detected in about one third of cells, which were randomly scattered between smooth muscle cells with cytoplasm not reactive for ERß. Almost all endothelial cells expressed ERß in their nuclei but not in the cytoplasm (Tables 1 and 2; Figure 1). PGR was negative in all cases and all tissues examined, even in the positive control.
|
|
|
Corpus Spongiosum (CS)
In corpus spongiosum, a more "venous" lacunary tissue, results were nearly comparable to those in CC. ER
could be detected in smooth muscle cells and some endothelia in the same seven cases where CC was immunoreactive for ER. In all 23 CS, smooth muscle showed strong ERß immmunoreactivity in the majority of cells, but there were more negative nuclei than in CC. All endothelia showed strong ERß staining. The only unequivocal difference from CC was found in five cases in which the AR could not be detected in any cells. Generally, in the periurethral stroma layer, which passes into the CS, nuclear immunostaining of all expressed steroid receptors was more impressive than in the surrounding vessels. We could not find any significant influence of age, hypertension, or coronary heart disease on CC or CS receptor status.
Urethra
Urethral epithelium showed strong nuclear expression of AR, predominantly in the basal cell layer. Immunostaining decreased in the luminal direction to negative in the superficial cells. ER showed strongest positivity in the intermediate cells of all urethras explored, but staining was weaker than that of AR. Further, ERß was highly expressed in almost all nuclei, and, much more weakly, in the cytoplasm of epithelial cells of every urethra explored.
|
Discussion |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
In this study we investigated the distribution of AR, ER
, ERß, and PGR protein in human adult penile tissues including corpus cavernosum, corpus spongiosum, and urethra. AR was expressed in smooth muscle cells of all explored CC and 18 of 23 CS tissues, whereas AR was absent in endothelial cells of all vessels. These findings of AR distribution are in accordance with earlier reports of the expression of AR in developing human fetal penis, e.g., Kim et al. (2002), where in specimens older than 16 weeks of gestation CC showed the strongest AR expression of all penile tissues. This study group revealed a weaker immunoreactivity in CS and glans, which underlines our finding, that 5/23 CS lacked reactivity for AR. Kalloo et al. (1993) observed intense immunostaining of AR in CC in human fetuses. Furthermore, they detected strongest reactivity in the periurethral zone of the CS, exactly what we also observed in adult tissue. This might lead to the assumption that androgen not only regulates development in these areas but also helps to maintain normal cell function in vascular smooth muscle cells of the human penis. Evidence of the distribution of ER, known as "the" estrogen receptor until the ß-isoform was cloned, in penile tissue is diminished. In the interesting study of Kalloo et al. (1993), ER could not be found in developing human penis, whereas ER mRNA and protein were detected in rat penis very recently by Jesmin et al. (2002). New advances in antigen retrieval techniques, which increase sensitivity especially for steroid hormone staining of paraffin-embedded tissue, may account for the difference in these studies. Despite the fact that immunostaining was low, we obtained clear evidence of ER protein in CC and CS in 7/23 cases. Differentiation from negative results was difficult, so it can be assumed that some of the samples counted as negative actually do express ER protein in such low amounts that they cannot be detected with the antigen retrieval methods known today. On the other hand, variation in the ER status of human vasculature has been shown previously (e.g., Rogers et al. 1996). Chen et al. (1999) showed that ER can mediate the short-term effects of estrogen on eNOS activity and may assist vasodilatation by releasing NO. Concerning possible interactions between AR and ER, as in ER-knockout male mice, in which lower expression of AR immunoreactivity was found in some areas of the brain by McAbee and DonCarlos (1999), we could not find any association between ER positivity and the amount of AR protein expression in human penile tissue. Beyond that, there was no significant influence of age or disease, such as hypertension or coronary artery disease, in remodeling the vasculature or on CC or CS receptor status. We must admit that the numbers of samples in this study were too low to provide statistically relevant statements. We showed that ERß is the predominant ER subtype in human penile cavernous tissue. ERß is abundantly expressed in both smooth muscle cells and endothelium of the CC and the CS, the urethral epithelium, and the urethral glands. Although this is the first evidence of ERs in human adult penile tissue, it matches one earlier report of ER and ERß in developing rat penis by Jesmin et al. (2002), who found less pronounced expression of ERß in adult rats. In our data on human cavernous tissue, ERß is dominant in almost all cells. In the endothelium, known to be the key regulator of vascular integrity, ERß was found in this study to be expressed ubiquitously but ER only sporadically. A comparable result was described first in vascular endothelium of rat uterus by Wang et al. (1999), and then in vessels of human endometrium (Critchley et al. 2001), where ERß was the only steroid receptor expressed. Moreover, a number of studies have shown ER to be important in the functioning and growth of endothelium both in vitro and in vivo, e.g., Brouchet et al. (2001) and Gargett et al. (2002), where estrogen tends to mediate transcription via ER rather than ERß. Therefore, estrogen incubation increased VEGFR-2 expression and VEGF binding only in ER-positive myometrial microvascular endothelial cells, but expression of ER was low and variable among subjects (13 of 21 samples). In that study, the VEGFR system was not associated with ERß expression, but ERß mRNA and protein could be demonstrated at a higher level than ER in every sample. Beyond this, ERß has been demonstrated not only in the vasculature of the uterus but also in great vessels (Taylor and Al-Azzawi 2000) and umbilical vein endothelial cells (Stefano et al. 2000). It has been suggested that ERß mediates some of the direct effects of estradiol on the vasculature. For example, ERß mRNA is upregulated in endothelial and luminal smooth muscle cells after balloon injury (Lindner et al. 1998) and inhibits the vascular injury response in ER-deficient mice (Iafrati et al. 1997). Interestingly, all samples were negative for PGR, which has often been found to be co-expressed with ERs. Moreover, there is clear evidence that progesterone can influence the proliferation of endothelial cells (Vázquez et al. 1999). Although extended parts of human vasculature seem to be susceptible to progesterone, some studies have revealed heterogeneous staining patterns for PGR, e.g., in endometrial vascular endothelial cells (Rogers et al. 1996), or completely negative results, e.g. in telangiectasias (Sadick and Niedt 1990). In the male reproductive system, PGR has been demonstrated in prostate and epididymal epithelial cells, but the same study (Ergun et al. 1997) found epididymal vascular endothelial cells ER-positive but PGR-negative in all regions of the organ. Accordingly, progesterone seems to be subordinate for vascular function of human epididymis and penis.
The relevance of androgens and other sex hormones, particularly estrogen, in the modulation of the structure and function of the urothelium and the distal urethra is not yet understood. Although two reports also described strong reactivity of AR in developing human and adult rat urethra by IHC (Salmi et al. 2001; Kim et al. 2002), there is no evidence in adult human male urethra. In our study, the basal cells markedly expressed AR, indicating that androgen is involved in the growth of human male urothelium. Whereas in the male rat urethra, Makela et al. (2000) could not detect ER by in situ hybridization and IHC, a more recent study found weak ER protein expression in the proximal and distal female urethra (Blakeman et al. 2000). However, the importance of moderate expression of ER in the suprabasal layer of male urothelium remains unclear, particularly because ERß, which is known to exert inverse transcriptional effects, is highly expressed in almost all epithelial cells. Here, our results showing strong expression in nuclei of the epithelial cells and, additionally, moderate cytoplasmic expression are in agreement with all previous studies in male rat urethras.
In view of the observation that ERß is expressed in human penile vasculature and urothelium in excess to the other sex steroid receptors, we propose that estrogen could play a significant role in penile blood vessel regulation and epithelial function, operating preferably on the ERß-isoform. It can be suggested that estrogen's action supports resistance to increased mechanical and hemodynamic stress, according to Lindner et al. (1998), and maintains vascular tone and perhaps erectile function. Further studies will be needed to discover estrogen-regulated genes, especially those being controlled by ERß, in the male reproductive system, and to clarify the possible involvement of aromatization of androgens to estrogen in penile tissue.
|
Footnotes |
|---|
Received for publication June 20, 2003; accepted October 16, 2003
|
Literature Cited |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Batra S, Bjellin L, Iosif S, Martensson L, Sjögren C (1985) Effect of oestrogen and progesterone on the blood flow in the lower urinary tract of the rabbit. Acta Physiol Scand 123:191–194[Medline]
Blakeman PJ, Hilton P, Bulmer JN (2000) Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. Br J Urol 86:32–38
Bodker A, Bruun J, Balslev E, Iversen HG, Meyhoff HH, Andersson KE (1999) Estrogen receptors in the human male prostatic urethra and prostate, in prostatic cancer and benign prostatic hyperplasia. Scand J Urol Nephrol 33:237–242[Medline]
Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor- but not estrogen receptor-ß. Circulation 103:423–428
Chen Z, Yuhanna IS, Galcheva–Gargova Z, Karas RH, Mendelsohn ME, Shaul P (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401–406[Medline]
Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Milliar MR, et al. (2001) Estrogen receptor ß, but not estrogen receptor , is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 86:1370–1378
Ergun S, Ungefroren H, Holstein AF, Davidoff MS (1997) Estrogen and progesterone receptors and estrogen receptor-related antigen (ER-D5) in human epididymis. Mol Reprod Dev 47:448–455[Medline]
Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ (2002) Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143:3785–3795
Fan X, Olson SJ, Blevins LS, Allen GS, Johnson MD (2002) Immunohistochemical localization of carboxypeptidases D, E, and Z in pituitary adenomas and normal human pituitary. J Histochem Cytochem 50:1509–1516
Gargett CE, Zaitseva M, Bucak K, Chu S, Fuller PJ, Rogers PAW (2002) 17ß-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor- and -ß. J Clin Endocrinol Metab 87:4341–4349
Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340–352
Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O'Donnell TF, et al. (1997) Estrogen inhibits the vascular injury response in estrogen receptor -deficient mice. Nature Med 3:545–548[Medline]
Jenner MR, Kelch RP, Kaplan SL, Grumbach MM (1972) Hormonal changes in puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor. J Clin Endocrinol Metab 34:521–530[Medline]
Jesmin S, Mowa CN, Matsuda N, Salah–Eldin AE, Togashi H, Sakuma I, Hattori Y, Kitabatake A (2002) Evidence for a potential role of estrogen in the penis: detection of estrogen receptor-alpha and -beta messenger ribonucleic acid and protein. Endocrinology 143:4764–4774
Kalloo NB, Gearhart J, Barrack E (1993) Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genitalia. J Clin Endocrinol Metab 77:692–698[Abstract]
Karas RH, Patterson BL, Mendelsohn ME (1994) Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 19:1943–1950
Kim KS, Liu W, Cunha GR, Russell DW, Huang H, Shapiro E, Baskin LS (2002) Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res 307:145–153[Medline]
Kuiper GG, Karlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863–870
Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME (1998) Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 27;83:224–229
Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson JA, et al. (1999) Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci USA 896:7077–7082
Makela S, Strauss L, Kuiper G, Valve E, Salmi S, Santti R, Gustafsson JA (2000) Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol 22;170(1–2):219–229
McAbee MD, DonCarlos LL (1999) Estrogen, but not androgens, regulates androgen receptor messenger ribonucleic acid expression in the developing male rat fore brain. Endocrinology 140:3674–3681
Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801–1811
Rogers PA, Lederman F, Kooy J, Taylor NH, Healy DL (1996) Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Hum Reprod 11:2003–2008
Sadick NS, Niedt GW (1990) A study of estrogen and progesterone receptors in spider telangiectasias of the lower extremities. J Dermatol Surg Oncol 16:620–623[Medline]
Salmi S, Santti R, Gustafsson JA, Makela S (2001) Co-localization of androgen receptor with estrogen receptor ß in the lower urinary tract of the male rat. J Urol 166:674–677[Medline]
Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ, Speirs V (2002) Evaluation of seven oestrogen receptor ß antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 197:155–162[Medline]
Staffieri JJ, Badano H, Celoria G (1965) Study of testicular estrogenic production in normal individuals and in patients with various alterations of the seminiferous tube. Rev Iber Endocrinol 12:85–93[Medline]
Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, et al. (2000) Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101:1594–1597
Taylor AH, Al-Azzawi F (2000) Immunolocalization of oestrogen receptor beta in human tissues. J Mol Endocrinol 24:145–155[Abstract]
Vázquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW, Iruela-Arispe ML (1999) Progesterone regulates proliferation of endothelial cells. J Biol Chem 274:2185–2192
Wang H, Masironi B, Eriksson H, Sahlin L (1999) A comparative study of estrogen receptors alpha and beta in the uterus. Biol Reprod 61:955–964
Windahl SH, Norgard M, Kuiper GG, Gustafsson JA, Andersson G (2000) Cellular distribution of estrogen receptor beta in neonatal rat bone. Bone 26:117–121[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Ban, F. Sata, N. Kurahashi, S. Kasai, K. Moriya, H. Kakizaki, K. Nonomura, and R. Kishi Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias Hum. Reprod., June 1, 2008; 23(6): 1466 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Beleza-Meireles, V. Tohonen, C. Soderhall, C. Schwentner, C. Radmayr, I. Kockum, and A. Nordenskjold Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias Eur. J. Endocrinol., May 1, 2008; 158(5): 729 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Beleza-Meireles, I. Kockum, F. Lundberg, C. Soderhall, and A. Nordenskjold Risk Factors for Hypospadias in the Estrogen Receptor 2 Gene J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3712 - 3718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H O Goyal, T D Braden, C S Williams, and J W Williams Role of estrogen in induction of penile dysmorphogenesis: a review Reproduction, August 1, 2007; 134(2): 199 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H O Goyal, T D Braden, P S Cooke, M A Szewczykowski, C S Williams, P Dalvi, and J W Williams Estrogen receptor-{alpha} mediates estrogen-inducible abnormalities in the developing penis Reproduction, May 1, 2007; 133(5): 1057 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Watanabe, R. Yoshida, K. Ueoka, K. Aoki, I. Sasagawa, T. Hasegawa, K. Sueoka, N. Kamatani, Y. Yoshimura, and T. Ogata Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities Hum. Reprod., May 1, 2007; 22(5): 1279 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Dietrich, A. Haitel, G. Holzer, J. C. Huber, A. Kolbus, and W. Tschugguel Estrogen Receptor-{beta} Is the Predominant Estrogen Receptor Subtype in Normal Human Synovia Reproductive Sciences, October 1, 2006; 13(7): 512 - 517. [Abstract] [PDF]
|
|
|
|
 |
|
 S Jesmin, C N Mowa, I Sakuma, N Matsuda, H Togashi, M Yoshioka, Y Hattori, and A Kitabatake Aromatase is abundantly expressed by neonatal rat penis but downregulated in adulthood J. Mol. Endocrinol., October 1, 2004; 33(2): 343 - 359. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |